Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Probably neither.
It's rather clear the present senior executive leadership are long term players. It's their baby and they seem to be enjoying this ride.
That is posdible
Great point. The absolute gain is 100% of the Short price x the number of shares. The risk of loss is infinite if the price continues to rise.
Thank you.
The burden of the Shorts is an infinite negative return while at best a 100% gain. They are inherently speculating on failure.
The virtue of the Longs is they have infinite gain and perhaps the risk of 100% loss. They are participating by investment in a wonderful story.
Thank you.
When short interest is high it may very well be a bullish sign, as traders attempt to cover their positions.
May be true that Shorts do not need to rationally cover their positions. However they may feel otherwise as the price continues to increase.
And the strategic announcement of the GIFT (GrowLife Infrastructure and Technology) program for growers.
There was a new investment report last week that confirmed .23- that might have been the source of the gap.
Closest parallel industry from the dot.com bust is the SaaS companies, such as Taleo, RightNow Technologies, Salesforce.com, and Concur Technologies.
Ticket symbol may need to be changed to more reflect the GrowLife brand.
Nice post.
PHOT is a great story.
Or billionaires.
There are two tails to the normalized curve. Those that stay in the middle are safer but can reap less profit.
That's a great strategy. The reverse can be played out too- in other words, stay long unless fundamentals change. Your outcome metrics are right on target.
This is a very important question- what confidence do we have with this company right now, versus at .10?
I may have some experience with this, having bought shares of a company at $0.91 twelve years ago. Today it is at $107.
Common traits between the two companies- senior management is heavily invested (Sterling has $124M shares, floor at .03), new business model in new market, continued and consistent evidence of collaboration (mergers), transparency, a steady source of new concrete developments, proven management, unusual expertise, and brilliant strategy.
Concur
A key differentiator in this penny stock is the transparency that senior management has volunteered. There are few companies that consistently report fully audited SEC statements on a voluntary basis. In fact, this is the only corporation in this industry that does so. At the very least, investors should be heartened at their ability to make informed decisions.
GrowLife may be analogous to Blackberry ten years ago: first mover advantage, new market/new products, disruptive innovation, great management.
High short interest is usually a great sign for the Longs
Rob Hunt is Chairman of the Coalition of Responsible Patient Care in Massachusetts. Here is a link to a one hour interview. Serious investors may wish to view. This video was instrumental in my investment on Aug 09 of 1M shares at .0314:
http://www.crpc-ma.org/
Welcome Back!
Look for news in the near future on their Advisory boards selections. Might be very interesting.
Brilliant strategy. Ergo the recent financing!
Absolutely agree. Financing is critical at this point in the game. Financing implies trust. Trust is good.
Thank you, great explanation
Buy more at low prices.
GrowLife has an excellent Investors web page that contains fully audited SEC statements which answers many of the questions posted on this Board.
GrowLife is embarked on a timely and aggressive expansion plan that at the moment cannot be funded by organic revenue. That is why investors such as ourselves share in the risk by providing capital to senior executives that we trust will deploy wisely. With greater risk, investors expect a greater return.
A 100% return in the share price of PHIT in the last month is a great start.
Nice comments. Raising capital is the most critical issue for the GrowLife. This is really great news. 7% convertible bond is fantastic for a company this size.
Managing expectations of investors will be key to the ability to raise capital in this nascent stage of expansion. At this point, meeting/exceeding revenue projections might be the data point to monitor.
If senior management can supply metrics for investors that reliably predict revenue forecasts, it may substantially raise the value (trust) of this company.
In addition this instrument can be refinanced
Nice analysis. Concur.
Visibility. Marketing for large investors.
Excellent updated Investor Presentation released yesterday. Filed to the SEC. A must read for the Longs.
The great thing about this board is the privacy that empowers each if us to share information. Appreciate everyone's input.
GrowLife's Investor web page has a collection of third party fully audited SEC statements.
Thank you Alan. Absolutely enjoyed your webinar- essential information for serious investors/traders of PHOT.
http://www.marketfy.com/product/420investor/lessons/816/view/32200/
Another article-this is the best one:
http://secfilings.com/News.aspx?title=growlife_expands_market_presence_with_cannabis.org_portal&naid=550
Absolutely.....as well as pain relief and anti nausea properties. The legalization of medical cannabis is tightly coupled to patient empowerment and choice. Our senior executives including Rob Hunt are actively leading the movement in multiple states. That is really building the GrowLife brand.